Cryo-Cell International, Inc.
CCEL
$7.17
$0.14262.03%
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.53% | 0.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.53% | 0.30% | |||
| Cost of Revenue | -23.01% | 4.99% | |||
| Gross Profit | 7.52% | -1.28% | |||
| SG&A Expenses | 44.84% | 3.19% | |||
| Depreciation & Amortization | 0.72% | 225.42% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.26% | 5.00% | |||
| Operating Income | -108.80% | -17.29% | |||
| Income Before Tax | -161.05% | -6.27% | |||
| Income Tax Expenses | 210.54% | -59.80% | |||
| Earnings from Continuing Operations | -277.01% | 60.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -277.01% | 60.37% | |||
| EBIT | -108.80% | -17.29% | |||
| EBITDA | -92.38% | -8.78% | |||
| EPS Basic | -276.99% | 61.39% | |||
| Normalized Basic EPS | -199.11% | -42.26% | |||
| EPS Diluted | -277.54% | 62.50% | |||
| Normalized Diluted EPS | -200.60% | -42.27% | |||
| Average Basic Shares Outstanding | 0.06% | -0.68% | |||
| Average Diluted Shares Outstanding | -1.31% | -0.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
